Stay updated on Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 is visible, with no changes to the study content or layout observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page update is a minor template revision from v3.4.0 to v3.4.1. It does not affect core study content, eligibility criteria, outcomes, or listed locations.SummaryDifference0.0%

- Check26 days agoChange DetectedNo significant changes detected between the two screenshots; the page content and layout appear unchanged.SummaryDifference0.0%

- Check33 days agoChange DetectedGlossary visibility controls were added (Show glossary / Hide glossary). The page revision label was updated to Revision: v3.4.0, and capitalization changes were applied to related labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data').SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange Detected- Locations section reorganized: state/province-specific headers were removed and a consolidated list of locations is now displayed. A new Revision: v3.3.3 tag was added, replacing Revision: v3.3.2.SummaryDifference1%

Stay in the know with updates to Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.